CN102793840A - Mongolian compound preparation for treating bronchitis and preparation method thereof - Google Patents
Mongolian compound preparation for treating bronchitis and preparation method thereof Download PDFInfo
- Publication number
- CN102793840A CN102793840A CN2012103141229A CN201210314122A CN102793840A CN 102793840 A CN102793840 A CN 102793840A CN 2012103141229 A CN2012103141229 A CN 2012103141229A CN 201210314122 A CN201210314122 A CN 201210314122A CN 102793840 A CN102793840 A CN 102793840A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- compound preparation
- mongolian
- volatile oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Mongolian compound preparation for treating bronchitis and a preparation method thereof. The Mongolian compound preparation comprises the following raw materials in part by weight: 630 parts of sea buckthorn, 450 parts of white grape, 180 parts of coastal glehnia root, 180 parts of liquorice, 180 parts of lacca, 135 parts of pomegranate, 135 parts of costus root, 90 parts of dragonwort, 90 parts of rhizoma cyperi, 90 parts of bulbus fritillariae cirrhosae, 54 parts of safflower, 54 parts of cinnamon, 45 parts of hawthorn, 45 parts of cape jasmine, 45 parts of gypsum, 717 parts of dextrin and 5 parts of aspartame. The Mongolian compound preparation has the effects of clearing lung, eliminating phlegm and relieving cough and asthma. The Mongolian compound preparation is used for Mongolian medicine syndromes like lung heat, dry cough, thick and more phlegm, chest expansion, dyspnea, chronic cough and breath shortness as well as the syndromes like modern medicine tracheitis, chronic bronchitis, cough, expectoration, dyspnea and emphysema.
Description
Technical field
The present invention relates to medical technical field, bronchitic mongolian medicine compound preparation of in particular a kind of treatment and preparation method thereof.
Background technology
Traditional Mongolian medicine is national the medicine and pharmacology theory and the Therapeutic Method of the uniqueness of accumulation gradually of Mongolia.Traditional Mongolian medicine is one of Mongolian national rich cultural heritages, also is the important component part of Chinese medicine.It is the basis with the traditional medical practical experience that is accumulated in fighting back the disease for a long time; It has absorbed the theoretical elite of Tibetan medicine, Chinese medicine and ancient Hindu medicine, progressively forms the national tradition medical science with distinct national characters, region characteristic and unique theoretical system, clinical characters.The Mongolian medicine has the history in more than 2,000 year, lives in extremely frigid zones in conjunction with the Mongolian, many outdoor activities, and the characteristics of fleshiness food have developed own special advantages.Basically also be to cure the disease with methods such as medical herbs, acupuncture, massages; Also receive the influence of the Chinese traditional Chinese medical science very big therebetween, the supertition of the Shamanism of also mixing in the past is as jumping manito and so on; But study now; Discarding dross, the same as Chinese medicine, become a kind of medical approaches that administrative department of public health of the People's Republic of China (PRC) is admitted.
Traditional Mongolian medicine is thought when medicine will be described the acting complex relationship of human body, at first will study the unity of opposites that comprises on the whole universe and the earth between the human animals and plants, the dialectical relationship that interdepends and deposit.All things on earth will be kept ecological balance in the world, principal element normal and that deposit is the restriction or checking relation in five elements relations such as mutual nourishing, opposition, inhibition, increase and decrease, infiltration and quilt infiltration that all exist between them to a certain degree.Doctor's whole process of preventing and curing diseases is to utilize the contradiction of the unity of opposites between medicine and the human body to solve after the body generation pathological changes, gets back and recovers normal or life-prolonging purpose.
At present, treating acute tracheobronchitis clinically is main with drug therapy, and the acute tracheobronchitis pilosity is born in child and old people.These crowds are the special concern colonies in health-care hospital field.
Summary of the invention
Technical problem to be solved by this invention is that the deficiency that is directed against prior art provides bronchitic mongolian medicine compound preparation of a kind of treatment and preparation method thereof.
Technical scheme of the present invention is following:
The bronchitic mongolian medicine compound preparation of a kind of treatment, raw materials used medicine of mongolian medicine compound preparation and weight portion thereof are: 630 parts of Fructus Hippophaes; 450 parts of Fructus Vins; 180 parts of Radix Glehniaes; 180 parts in Radix Glycyrrhizae; 180 parts of Laccas; 135 parts of Punica granatum L.s; 135 parts of the Radix Aucklandiae; 90 parts of Rhizoma Bistortaes; 90 parts of Rhizoma Cyperis; 90 parts of Bulbus Fritillariae Cirrhosaes; 54 parts on Flos Carthami; 54 parts of Cortex Cinnamomis; 45 parts of Fructus Crataegis; 45 parts of Fructus Gardeniaes; 45 parts in Gypsum Fibrosum (system); 717 parts in dextrin; 5 parts of sweeteners.
The bronchitic mongolian medicine compound preparation of described treatment volume method for preparing; Get Fructus Hippophae, Radix Glehniae, Radix Glycyrrhizae, Rhizoma Bistortae, Flos Carthami, Fructus Crataegi, Fructus Gardeniae, Fructus Vins, Punica granatum L. and be ground into granule, add 8 times of amounts of ethanol of 70%, reflux, extract, 1h; Extract altogether 3 times; Merge to filter, 50 ℃ of decompression recycling ethanols concentrate extracting solution I, subsequent use; After above-mentioned medicinal residues are flung to residual ethanol, add 8 times of amount distilled water reflux, extract, 3 hours, merged and filter extracting solution II, subsequent use;
Get the Radix Aucklandiae, Cortex Cinnamomi, Rhizoma Cyperi pulverizing, cross 20 mesh sieves, add 10 times of water gagings, soaked 3 hours, extract volatile oil with steam distillation.The volatile oil that proposes is dissolved in dehydrated alcohol in 1: 1 ratio, gets dry powder I with β-CDBao He;
Its volatile oil uses the best enclose condition of β-CDBao He to be: volatile oil: β-CD is 1: 4 (mL: g), add 80 times of amounts of water, ultrasonic 15min under 50 ℃ of conditions;
Above-mentioned steam distillation extracts the distillation mother solution after volatile oil finishes, and filters, and gets extracting solution III, and is subsequent use;
Merge extractive liquid, I, extracting solution II, extracting solution III are spray dried to dry powder II;
Lacca is ground into granule, and with 95% alcoholic solution reflux, extract,, filtered while hot, filtrate decompression concentrate and reclaim ethanol, and 50 ℃ of vacuum drying to powder obtain dry powder III;
System Gypsum Fibrosum, Bulbus Fritillariae Cirrhosae are pulverized, cross 100 order medicines sieve dry powder IV;
With four dry powder of above gained and adjuvant mix homogeneously such as sweetener and dextrin, process soft material with 95% alcoholic solution as wetting agent, 60 ℃ of vacuum dryings, granulate, packing gets final product.
Described method for preparing, said spray drying optimum condition is: EAT is 100～110 ℃, solution density 1.02, sample introduction speed 22ml/min.
Removing heat from the lung and dissipating phlegm, relieving cough and asthma.Be used for lung-heat dry cough, the thick abundant expectoration of expectorant, the breast Mongolian medicine's syndrome such as pant, chronic cough is breathed hard that expands; Be equivalent to the modern medicine bronchitis, chronic bronchitis and cough and expectoration thereof, dyspnea, diseases such as emphysema.
Fructus Hippophae described in the side is the dry mature fruit of Elaeangnaceae plant Fructus Hippophae Hippophae rhamnoides L., should meet the pertinent regulations under the 171st page of Fructus Hippophae item of Pharmacopoeia of the People's Republic of China version in 2010; Fructus Vins is the dry mature fruit of vitaceae Vitis vinifera, should meet pertinent regulations under the 12nd page of Fructus Vins item of " Drug Standard of Ministry of Public Health of the Peoples Republic of China " version " mongolian medicine fascicle " in 1998; Gypsum Fibrosum is the Gypsum Fibrosum Gypsum Fibrosum of Sulfates mineral anhydrite family, the main hydrous calcium sulfate (CaSO that contains
42H
2O), should meet pertinent regulations under the 87th page of Gypsum Fibrosum item of Pharmacopoeia of the People's Republic of China version in 2010; Radix Glehniae is the dry root of samphire glehnia littoralis Clehnia littoralis Fr.Schmidtex Miq., should meet the pertinent regulations under the 92nd page of Radix Glehniae item of Pharmacopoeia of the People's Republic of China version in 2010; Radix Glycyrrhizae is the dry root and rhizome of glycyrrhizic legume Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat. Glycyrrhiza inflate Bat. or Glycyrrhiza glabra L. Glycyrrhiza glabra L., should meet the pertinent regulations under the 80th page of Radix Glycyrrhizae item of Pharmacopoeia of the People's Republic of China version in 2010; The Radix Aucklandiae is the dry root of feverfew Radix Aucklandiae Aucklandia lappa Decne., should meet the pertinent regulations under the 57th page of Radix Aucklandiae item of Pharmacopoeia of the People's Republic of China version in 2010; Lacca is the secreted colloid of Lacciferidae insecticide lac insect Laccifer lacca Kerr., should meet pertinent regulations under " Inner Mongol mongolian medicine material standard " the 491st page of Lacca item in 1987; Punica granatum L. is dry mature fruit or the seed of Punicaceae plant Punica granatum L. Punica granatum L., should meet the pertinent regulations under " Inner Mongol mongolian medicine material standard " the 391st page of Punica granatum L. item in 1987; Rhizoma Cyperi is the dry rhizome of sedge dried tuber Cyperus rotundus L., should meet the pertinent regulations under the 241st page of Rhizoma Cyperi item of Pharmacopoeia of the People's Republic of China version in 2010; Rhizoma Bistortae is the dry rhizome of polygonaceae plant Rhizoma Bistortae Polygonum bistorta L, should meet the pertinent regulations under the 271st page of Rhizoma Bistortae item of Pharmacopoeia of the People's Republic of China version in 2010; Bulbus Fritillariae Cirrhosae is liliaceous plant Bulbus Fritillariae Cirrhosae Fritillaria cirrhosa D.Don, dark violet Bulbus Fritillariae Uninbracteatae Fritillaria unibracteata Hsiao et K.C.Hsia, Gansu Bulbus Fritillariae Uninbracteatae Fritillaria przewalskii Maxim., rib sand Bulbus Fritillariae Uninbracteatae Fritillaria delavayi Franch., Bulbus Fritillariae taipaiensis Fritillaria taipaiensisP; Y; Li or Fritillaria wabuensis Fritillaria unibracteata Hsiao et K.C.Hsia var.wabuensis (S.Y. Tang et S.C.Yue) Z.D.Liu; The dry bulb of S.Wang et S.C.Chen should meet the pertinent regulations under the 34th page of Bulbus Fritillariae Cirrhosae item of Pharmacopoeia of the People's Republic of China version in 2010; Flos Carthami is the dried floral of feverfew Flos Carthami Carthamus tinctorius L., should meet the pertinent regulations under the 141st page of Flos Carthami item of Pharmacopoeia of the People's Republic of China version in 2010; Cortex Cinnamomi is the dry bark of canella Cortex Cinnamomi Cinnamomum cassia Presl, should meet the pertinent regulations under the 127th page of Cortex Cinnamomi item of Pharmacopoeia of the People's Republic of China version in 2010; Fructus Crataegi is the dry mature fruit of rosaceous plant Fructus Pyri Pashiae Crataegus pinnatifida Bge.Var.major N.E.Br. or Fructus Crataegi Crataegus pinnatifida Bge., should meet the pertinent regulations under the 29th page of Fructus Crataegi item of Pharmacopoeia of the People's Republic of China version in 2010; Fructus Gardeniae is the dry mature fruit of Maguireothamnus speciosus Fructus Gardeniae Gardenia jasminoides Ellis, should meet the pertinent regulations under the 231st page of Fructus Gardeniae item of Pharmacopoeia of the People's Republic of China version in 2010.
The specific embodiment
Below in conjunction with specific embodiment, the present invention is elaborated.
Embodiment 1, prescription and method for preparing:
1. write out a prescription: Fructus Hippophae 630g; Fructus Vins 450g; Radix Glehniae 180g; Radix Glycyrrhizae 180g; Lacca 180g; Punica granatum L. 135g; Radix Aucklandiae 135g; Rhizoma Bistortae 90g; Rhizoma Cyperi 90g; Bulbus Fritillariae Cirrhosae 90g; Flos Carthami 54g; Cortex Cinnamomi 54g; Fructus Crataegi 45g; Fructus Gardeniae 45g; Gypsum Fibrosum (system) 45g; Dextrin 717g; Sweetener 5g; Process the bronchitic mongolian medicine compound granular formulation of treatment of the present invention 1000kg.
2. preparation technology: above ten five tastes, get Fructus Hippophae, Radix Glehniae, Radix Glycyrrhizae, Rhizoma Bistortae, Flos Carthami, Fructus Crataegi, Fructus Gardeniae, Fructus Vins, Punica granatum L. and be ground into granule, add 8 times of amounts of ethanol of 70% (liquid by volume solid medicine by weight.Like g and ml or kg and L.Here the medical material that refers to is g, and ethanol is ml.Down with), reflux, extract, 1h extracts 3 times altogether, merge to filter, 50 ℃ of decompression recycling ethanols concentrate extracting solution I, subsequent use;
After above-mentioned medicinal residues are flung to residual ethanol, add 8 times of amount distilled water reflux, extract, 3 hours, merged and filter extracting solution II, subsequent use;
Get the Radix Aucklandiae, Cortex Cinnamomi, Rhizoma Cyperi pulverizing, cross 20 mesh sieves, add 10 times of water gagings (2800ml), soaked 3 hours, extract volatile oil with steam distillation.The volatile oil that proposes is dissolved in dehydrated alcohol in 1: 1 ratio, gets dry powder I with β-CD (beta-schardinger dextrin-) enclose;
Its volatile oil uses the best enclose condition of β-CDBao He to be: volatile oil: β-CD is 1: 4 (mL: g), add 80 times of amounts (mL) of water volatile oil, ultrasonic 15min under 50 ℃ of conditions.
Above-mentioned steam distillation extracts the distillation mother solution after volatile oil finishes, and filters, and gets extracting solution III, and is subsequent use.Medicinal residues discard;
Merge extractive liquid, I, extracting solution II, extracting solution III are spray dried to dry powder II, and the spray drying optimum condition is: EAT is 100～110 ℃, solution density 1.02, sample introduction speed 22ml/min.
Lacca is ground into granule, and with 95% alcoholic solution reflux, extract,, filtered while hot, filtrate decompression concentrate and reclaim ethanol, and 50 ℃ of vacuum drying to powder obtain dry powder III;
System Gypsum Fibrosum, Bulbus Fritillariae Cirrhosae are pulverized, cross 100 order medicines sieve dry powder IV.
With four dry powder of above gained and adjuvant mix homogeneously such as sweetener and dextrin, process soft material with 95% an amount of alcoholic solution (95% amount of ethanol is according to the control of soft material situation) as wetting agent, 60 ℃ of vacuum dryings, granulate, packing gets final product.Every bag of 2.5g, 10 bags in every box.Oral, one time 1 bag, 2 times on the one.Removing heat from the lung and dissipating phlegm, relieving cough and asthma.Be used for lung-heat dry cough, the thick abundant expectoration of expectorant, the breast Mongolian medicine's syndrome such as pant, chronic cough is breathed hard that expands; Be equivalent to the modern medicine tracheitis, chronic bronchitis and cough and expectoration thereof, dyspnea, diseases such as emphysema.
Embodiment 2, clinical data
Erdos Mongolian medicine's institute 2004 carries out clinical observation to 160 acute bronchitis patients, sums up compound granular formulation to acute tracheitis-bronchitic curative effect.The result shows: when the treatment acute tracheobronchitis was cured 5.39%, the 5 day in the time of the 3rd day 80.77%, the 7 day the time cure rate reach 100%; The disappearance rate of expectoration symptom reaches expectoration symptom complete obiteration in 97.77%, one week when being 63.33%, 5 day in the time of 3 days; Cure 33.33% in the time of 7 days with matched group (niuhuang shedan chuanbei mixture) and compare, significant differences (p＜0.01) is arranged.It is thus clear that the curative effect of symptoms such as the cough that compound granular formulation causes for acute bronchitis, expectoration is fast and reliable, especially the sharp expectorant effect to the expectoration patient is more obvious.
(1) all persons of accepting for medical treatment of physical data are Ordos City Mongolian medicine's institute internal medicine, Pediatric Clinic patient, and 160 routine patients are by be divided into treatment group and matched group at random, and 130 examples are organized in treatment, matched group 30 examples.The treatment group: male 79 examples, women 51 examples, the age, course of disease weak point was 2 days 6 months～58 years old (average 11.97 years old), length is 11 days, average 4.03 days.All be cough, expectoration is the acute tracheobronchitis patient of cardinal symptom; Matched group: male 12 examples, women 18 examples, the age is 3～46 years old (average 15.8 years old), and the course of treatment, weak point was 1 day, and length is 7 days, and average 3.3 days, all with cough, expectoration was the acute tracheobronchitis patient of cardinal symptom.Two groups of patient's chest X ray examinations are all no abnormal.Two groups of various data explain to have comparability through X 2 test P＞0.05 there was no significant difference.
(2) the each 2.5g of Therapeutic Method treatment group: embodiment 1 gained compound granular formulation is oral, every day 2 times, (serveing on a week is 1 course of treatment).Matched group: niuhuang shedan chuanbei mixture (producing (88) by Sanghai Pharmaceutical Factory defends the accurate word z-16 of medicine number), each 10～20mL is oral, and every day 3 times, serveing on for 1 week is 1 course of treatment.Observational technique: checked respectively or followed up a case by regular visits to and kept a record in the 1st, 3,5,7 day in prescription on individual diagnosis.Estimated clinical efficacy respectively at the 3rd, 5,7 day.Made the evaluation of toleration and untoward reaction on the 7th day respectively by doctor and patient.
(3) criterion of therapeutical effect and judgement clinical symptoms (cough) standards of grading: asymptomatic is 0 minute, slightly is 1 minute, and moderate is 2 minutes, and severe is 3 minutes.Curative effect determinate standard and result: use integration method and carry out efficacy determination: 1. cure: cough, the complete obiteration of expectoration symptom, integration add up to decline more than 95%; 2. produce effects: cough, expectoration symptom disappear basically, and integration adds up to and descends more than 70%; 3. take a turn for the better: cough, expectoration sx, integration add up to decline more than 50%; 4. invalid: cough, expectoration symptom do not have obvious improvement, and the integration total is declined by less than 50%.
(4) efficacy result treatment group: cure 7 examples (5.39%) in the time of the 3rd day, produce effects 111 examples (85.38%), 12 examples that take a turn for the better (9.23%), invalid 0 example; Cure 98 examples (75.38%) in the time of the 5th day, produce effects 25 examples (19.23%); Cure in the time of the 7th day, cure rate is 100% in 1 week.Matched group: cure 0 example in the time of the 3rd day, produce effects 0 example, invalid 30 examples (100%); Cure 0 example in the time of the 5th day, produce effects 5 examples (16.67%), 18 examples that take a turn for the better (60%), invalid 7 examples (23.3%); Cure 10 examples (33.3%) in the time of the 7th day, produce effects 14 examples (46.6%), 5 examples that take a turn for the better (16.6%), cure rate is 33.3% (P＜0.01) in invalid (3.33%) 1 week of 1 example.Two groups of curative effect comparisions are seen table 1.
Table 1 compound granular formulation treatment group and matched group are relatively
Annotate: 130 examples are organized in treatment; Matched group: 30 examples.
Should be understood that, concerning those of ordinary skills, can improve or conversion, and all these improvement and conversion all should belong to the protection domain of accompanying claims of the present invention according to above-mentioned explanation.
Claims (4)
1. the bronchitic mongolian medicine compound preparation of treatment is characterized in that raw materials used medicine of mongolian medicine compound preparation and weight portion thereof are: 630 parts of Fructus Hippophaes; 450 parts of Fructus Vins; 180 parts of Radix Glehniaes; 180 parts in Radix Glycyrrhizae; 180 parts of Laccas; 135 parts of Punica granatum L.s; 135 parts of the Radix Aucklandiae; 90 parts of Rhizoma Bistortaes; 90 parts of Rhizoma Cyperis; 90 parts of Bulbus Fritillariae Cirrhosaes; 54 parts on Flos Carthami; 54 parts of Cortex Cinnamomis; 45 parts of Fructus Crataegis; 45 parts of Fructus Gardeniaes; 45 parts in Gypsum Fibrosum (system); 717 parts in dextrin; 5 parts of sweeteners.
2. the bronchitic mongolian medicine compound preparation of treatment according to claim 1 volume method for preparing is characterized in that, gets Fructus Hippophae, Radix Glehniae, Radix Glycyrrhizae, Rhizoma Bistortae, Flos Carthami, Fructus Crataegi, Fructus Gardeniae, Fructus Vins, Punica granatum L. and is ground into granule; Add 8 times of amounts of ethanol of 70%; Reflux, extract, 1h extracts 3 times altogether, merges to filter; 50 ℃ of decompression recycling ethanols concentrate extracting solution I, subsequent use; After above-mentioned medicinal residues are flung to residual ethanol, add 8 times of amount distilled water reflux, extract, 3 hours, merged and filter extracting solution II, subsequent use;
Get the Radix Aucklandiae, Cortex Cinnamomi, Rhizoma Cyperi pulverizing, cross 20 mesh sieves, add 10 times of water gagings, soaked 3 hours, extract volatile oil with steam distillation; The volatile oil that proposes is dissolved in dehydrated alcohol in 1: 1 ratio, gets dry powder I with β-CDBao He;
Above-mentioned steam distillation extracts the distillation mother solution after volatile oil finishes, and filters, and gets extracting solution III, and is subsequent use;
Merge extractive liquid, I, extracting solution II, extracting solution III are spray dried to dry powder II;
Lacca is ground into granule, and with 95% alcoholic solution reflux, extract,, filtered while hot, filtrate decompression concentrate and reclaim ethanol, and 50 ℃ of vacuum drying to powder obtain dry powder III;
System Gypsum Fibrosum, Bulbus Fritillariae Cirrhosae are pulverized, cross 100 order medicines sieve dry powder IV;
With four dry powder of above gained and adjuvant mix homogeneously such as sweetener and dextrin, process soft material with 95% alcoholic solution as wetting agent, 60 ℃ of vacuum dryings, granulate, packing gets final product.
3. method for preparing according to claim 2 is characterized in that, said spray drying optimum condition is: EAT is 100～110 ℃, solution density 1.02, sample introduction speed 22ml/min.
4. method for preparing according to claim 2 is characterized in that, described volatile oil uses the best enclose condition of β-CDBao He to be: volatile oil: β-CD is 1: 4 (mL: g), add 80 times of amounts of water, ultrasonic 15min under 50 ℃ of conditions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103141229A CN102793840A (en) | 2012-08-24 | 2012-08-24 | Mongolian compound preparation for treating bronchitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103141229A CN102793840A (en) | 2012-08-24 | 2012-08-24 | Mongolian compound preparation for treating bronchitis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102793840A true CN102793840A (en) | 2012-11-28 |
Family
ID=47193308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103141229A Pending CN102793840A (en) | 2012-08-24 | 2012-08-24 | Mongolian compound preparation for treating bronchitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102793840A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104740279A (en) * | 2015-03-04 | 2015-07-01 | 鄂尔多斯市蒙医研究所 | Mongolian medicine compound preparation for treating bronchitis and preparation method thereof |
| CN112294915A (en) * | 2020-10-22 | 2021-02-02 | 浏阳利美医院有限公司 | Pharmaceutical composition for treating emphysema and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138475A (en) * | 1996-01-22 | 1996-12-25 | 刘勇民 | Medicine for treatment of cough |
| CN1140087A (en) * | 1996-06-11 | 1997-01-15 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
| CN1352966A (en) * | 2000-11-10 | 2002-06-12 | 李庆福 | Medicine for treating tracheitis and asthma |
| CN101040967A (en) * | 2007-04-10 | 2007-09-26 | 赵宇明 | Mongol medicine for treating respiratory inflammation |
-
2012
- 2012-08-24 CN CN2012103141229A patent/CN102793840A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138475A (en) * | 1996-01-22 | 1996-12-25 | 刘勇民 | Medicine for treatment of cough |
| CN1140087A (en) * | 1996-06-11 | 1997-01-15 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
| CN1352966A (en) * | 2000-11-10 | 2002-06-12 | 李庆福 | Medicine for treating tracheitis and asthma |
| CN101040967A (en) * | 2007-04-10 | 2007-09-26 | 赵宇明 | Mongol medicine for treating respiratory inflammation |
Non-Patent Citations (1)
| Title |
|---|
| 赵宇明: "《蒙古族医药学》", 31 December 1997 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104740279A (en) * | 2015-03-04 | 2015-07-01 | 鄂尔多斯市蒙医研究所 | Mongolian medicine compound preparation for treating bronchitis and preparation method thereof |
| CN104740279B (en) * | 2015-03-04 | 2018-02-16 | 鄂尔多斯市蒙医研究所 | A kind of Mongolian compound preparation for treating bronchitis and preparation method thereof |
| CN112294915A (en) * | 2020-10-22 | 2021-02-02 | 浏阳利美医院有限公司 | Pharmaceutical composition for treating emphysema and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100441212C (en) | Chinese medicine for treating cardiac failure | |
| CN108030864A (en) | A kind of strong medicine liquid for treating traumatic injury, burn and inflammation | |
| CN103520696A (en) | Traditional Chinese medicine prescription used for treating heart qi deficiency syndrome type chest stuffiness and cardialgia | |
| CN103007012B (en) | Traditional Chinese medicine composition for treating toothaches and preparation method thereof | |
| CN103055285B (en) | Traditional Chinese medicine for treating forepart hepetocirrhosis and preparation method thereof | |
| CN102488874A (en) | Method for preparing bupleurum and cassia twig freeze-dried oral preparation | |
| CN103071120B (en) | Medicine for treating silicosis | |
| CN102247479A (en) | Antitumor strong medicine and preparation method thereof | |
| CN104800382A (en) | Traditional Chinese medicine composition for treating colds, as well as preparation method and application thereof | |
| CN102793840A (en) | Mongolian compound preparation for treating bronchitis and preparation method thereof | |
| CN103272136B (en) | Traditional Chinese medicine for treating climacteric syndrome of women | |
| CN104225399A (en) | Traditional Chinese medicine for treating pulmonary tuberculosis | |
| CN103169855A (en) | Drug composition for treating chronic heart failure | |
| CN105797092B (en) | Yiyuan anti-cold mixture | |
| CN104547875A (en) | Traditional Chinese medicine for treating arteries and veins stasis type chest stuffiness and pain | |
| CN103520673A (en) | Traditional Chinese medicine for treating deficiency of Qi and blood syndrome type of menopathy | |
| CN103055118A (en) | Traditional Chinese medicine for treating asthma | |
| CN102038834A (en) | Traditional Chinese medicine preparation for preventing and treating cancers | |
| CN105106540A (en) | Medicinal preparation for treating cerebral thrombosis | |
| CN105267296A (en) | Traditional Chinese medicine for treating erythema nodosum | |
| CN102836373B (en) | Medicament for treating infantile pneumonia | |
| CN102895322B (en) | Medicament composition for treating pulmonary interstitial fibrosis as well as preparation method and applications thereof | |
| CN103536853B (en) | The Chinese medicine for the treatment of deficiency of both the heart and spleen pattern of syndrome spleen fatiguing disease | |
| CN104398731A (en) | Traditional Chinese medicament for treating chronic hepatitis | |
| CN103690834A (en) | Antihypertensive traditional Chinese medicinal composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121128 |